Triple
T2138580
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lucentis |
E46708
|
entity |
| Predicate | isRelatedDrug |
P24601
|
FINISHED |
| Object |
aflibercept
Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
|
E238303
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88a174ab48190a5db20c132e5dccf |
elicitation | completed |
| NER | batch_69abc5af20808190902031d8c0bba376 |
ner | completed |
| NED1 | batch_69ae58d3275481909c8d74ca7c037ddd |
ned_source_triple | completed |
| NED2 | batch_69ae598b51248190900086fee72c1103 |
ned_description | completed |
| NEDg | batch_69ae5928f824819089f1044ebd5ff68e |
nedg | completed |
Created at: March 4, 2026, 7:44 p.m.